Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
27%
OVERLAP
BY WEIGHT
14
# OF OVERLAPPING
HOLDINGS
BBH
27
HOLDINGS
58%
ALSO IN BBP
BBP
65
HOLDINGS
23%
ALSO IN BBH
SECTOR DRIFT (BBH minus BBP)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
INSMED INC | 4.8% | 3.3% | 3.3% |
|
ALNYLAM PHARMACEUTICALS INC | 4.8% | 3.0% | 3.0% |
|
BEIGENE LTD. SPONSORED ADR | 4.1% | 2.9% | 2.9% |
|
GILEAD SCIENCES INC | 12.8% | 2.1% | 2.1% |
|
INCYTE CORP | 2.2% | 2.0% | 2.0% |
BBH Overweight Relative to BBP
|
AMGEN INC | 11.1% |
|
GILEAD SCIENCES INC | 10.7% |
|
VERTEX PHARMACEUTICALS INC | 8.1% |
 |
ARGENX SE ADR | 5.2% |
|
IQVIA HOLDINGS INC | 4.7% |
|
NATERA INC | 4.4% |
|
REGENERON PHARMACEUTICALS | 3.6% |
 |
ICON PLC | 3.4% |
|
ILLUMINA INC | 2.4% |
|
QIAGEN NV | 1.8% |
BBH Underweight Relative to BBP
|
BRIDGEBIO PHARMA, INC. | -3.2% |
|
RHYTHM PHARMACEUTICALS, INC. | -3.0% |
|
MIRUM PHARMACEUTICALS, INC. | -3.0% |
|
IONIS PHARMACEUTICALS, INC. | -2.7% |
|
INTRA-CELLULAR THERAPIES INC | -2.6% |
|
ASCENDIS PHARMA A/S | -2.6% |
|
HALOZYME THERAPEUTICS INC | -2.6% |
|
PHATHOM PHARMACEUTICALS, INC. | -2.5% |
|
SAGE THERAPEUTICS INC | -2.5% |
|
LIGAND PHARMACEUTICALS-CL B | -2.4% |